Shorts

0:58
Why Some RLS Medications Can Make Symptoms Worse
8 months ago
by
Louie Pasculli

1:33
Meeting the Needs of Underserved Multiple Sclerosis Populations
8 months ago
by
Marisa McGinley, DO(+1 more)

0:37
Early Identification and Newborn Screening for Neuromuscular Disorders
8 months ago
by
John F. Brandsema, MD(+1 more)

2:00
Data Behind EBNA1 Antibodies as Distinguishable Feature of Multiple Sclerosis
8 months ago
by
Marco Meglio

1:10
4 FDA-Approved Treatments for NMOSD You Should Know
8 months ago
by
Louie Pasculli

1:24
Clinical Value of EBNA1 Antibodies in MS, MOGAD, & NMOSD
8 months ago
by
Marco Meglio

1:01
Emerging CAR-T Therapy Approaches in NMOSD
8 months ago
by
Louie Pasculli

0:31
Addressing Access Barriers to Emerging Therapies in Neuromuscular Disease
8 months ago
by
Isabella Ciccone, MPH(+1 more)

1:33
Developing Pivotal Trials for Stem Cell-Based Agents in Multiple Sclerosis
8 months ago
by
Jeffrey Cohen, MD(+1 more)

0:48
MDA 2026: Accepting the MDA Legacy Award
8 months ago
by
Allison Moore(+1 more)

1:02
How Deramiocel Works
8 months ago
by
Noah Stansfield

0:51
Research and Collaboration in Neuromuscular Medicine
8 months ago
by
Marco Meglio(+1 more)

0:51
MDA 2026: Receiving the MDA Legacy Award
8 months ago
by
Michio Hirano, MD(+1 more)

0:51
MDA 2026: Future Vision of Neuromuscular Disorders
8 months ago
by
Isabella Ciccone, MPH(+1 more)

0:31
MDA 2026: Phase 2 ALKIVIA Study
8 months ago
by
Isabella Ciccone, MPH(+1 more)

0:47
MDA 2026: In the Shoes of the Patient
8 months ago
by
Isabella Ciccone, MPH(+1 more)

0:51
MDA 2026: The Future of Precision Medicine
8 months ago
by
Isabella Ciccone, MPH(+1 more)

1:33
Reasons Behind Eptinezumab's Effectiveness in Treatment-Resistant Migraine
8 months ago
by
Marco Meglio(+1 more)

0:56
Managing Neurologic Symptoms During Cancer Treatment
8 months ago
by
Ditte Primdahl, MD(+2 more)

0:49
Navigating Neurologic Complications During Cancer Therapy
8 months ago
by
Shailee Samir Shah, MD(+2 more)

1:32
Primary Care–Neurologist Collaboration After Stroke
8 months ago
by
Eva Mistry, MD (+1 more)

1:33
Assessing Potential of BD-Tau in Stroke-Related Brain Injury
8 months ago
by
Marco Meglio(+1 more)

0:55
Optimizing Immunotherapy in PNS During Cancer Care
8 months ago
by
Ditte Primdahl, MD(+2 more)

0:59
Managing Immunotherapy and Recovery in PNS
8 months ago
by
Shailee Samir Shah, MD(+2 more)

1:00
Differentiating PNS From Treatment-Related Neurotoxicity
8 months ago
by
Shailee Samir Shah, MD(+2 more)

1:01
Challenges in Diagnosing Paraneoplastic Neurologic Syndromes
8 months ago
by
Ditte Primdahl, MD(+2 more)

1:11
Differentiating Classic PNS from ICI-Related Toxicities
9 months ago
by
Ditte Primdahl, MD(+2 more)

0:27
Managing PNS in the Era of Immunotherapy
9 months ago
by
Shailee Samir Shah, MD(+2 more)

1:07
Prioritizing Malignancy Screening in Suspected PNS
9 months ago
by
Ditte Primdahl, MD(+2 more)

0:44
Screening Strategies for Suspected PNS
9 months ago
by
Shailee Samir Shah, MD(+2 more)
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 NIMBLE Trial: Cemdisiran Efficacy and Safety Results in gMG
2
Myelin Repair Research in MS: Lessons From Clinical Trials and the Road Ahead
3
From Glucose to Cognition: Where Repurposed Diabetes Drugs Stand in Alzheimer Disease
4
FDA Requires NAION Warning Across GLP-1 Receptor Agonist Class
5
